Vanda Pharmaceuticals Inc (VNDA)
4.845
+0.18
(+3.97%)
USD |
NASDAQ |
Nov 04, 16:00
4.845
0.00 (0.00%)
After-Hours: 20:00
Vanda Pharmaceuticals Profit Margin (Quarterly): -8.95% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -8.95% |
| March 31, 2024 | -8.74% |
| December 31, 2023 | -5.30% |
| September 30, 2023 | 0.35% |
| June 30, 2023 | 3.30% |
| March 31, 2023 | 5.20% |
| December 31, 2022 | 10.64% |
| September 30, 2022 | 5.01% |
| June 30, 2022 | 4.00% |
| March 31, 2022 | -10.68% |
| December 31, 2021 | 10.41% |
| September 30, 2021 | 11.09% |
| June 30, 2021 | 14.22% |
| March 31, 2021 | 13.80% |
| December 31, 2020 | 12.11% |
| September 30, 2020 | 9.86% |
| June 30, 2020 | 14.01% |
| March 31, 2020 | 0.84% |
| December 31, 2019 | 6.92% |
| September 30, 2019 | |
| June 30, 2019 | 19.52% |
| March 31, 2019 | -1.28% |
| December 31, 2018 | 19.53% |
| September 30, 2018 | 14.59% |
| June 30, 2018 | 9.74% |
| Date | Value |
|---|---|
| March 31, 2018 | 7.03% |
| December 31, 2017 | -4.15% |
| September 30, 2017 | -11.01% |
| June 30, 2017 | -3.65% |
| March 31, 2017 | -20.43% |
| December 31, 2016 | -1.58% |
| September 30, 2016 | -1.12% |
| June 30, 2016 | -12.82% |
| March 31, 2016 | -37.15% |
| December 31, 2015 | -46.46% |
| September 30, 2015 | -33.38% |
| June 30, 2015 | -19.53% |
| March 31, 2015 | -46.14% |
| December 31, 2014 | |
| September 30, 2014 | -9.65% |
| June 30, 2014 | -198.6% |
| March 31, 2014 | -290.2% |
| December 31, 2013 | -88.20% |
| September 30, 2013 | -62.07% |
| June 30, 2013 | -40.67% |
| March 31, 2013 | -56.01% |
| December 31, 2012 | -92.45% |
| September 30, 2012 | -64.26% |
| June 30, 2012 | -95.57% |
| March 31, 2012 | -97.80% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-10.68%
Minimum
Mar 2022
14.22%
Maximum
Jun 2021
4.64%
Average
5.20%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| Zevra Therapeutics Inc | -447.9% |
| Edgewise Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.01% |
| Return on Assets | -1.69% |
| Return on Invested Capital | -2.01% |
| Gross Profit Margin (Quarterly) | 94.59% |
| Operating Margin (Quarterly) | -20.10% |
| Return on Net Operating Assets | -8.78% |